Dihomo-gamma-linolenic acid in patients with atherosclerosis: effects on platelet aggregation, plasma lipids and low-density lipoprotein-induced inhibition of prostacyclin generation.
D015126:8,11,14-Eicosatrienoic Acid / Q000627:therapeutic use*; D001161:Arteriosclerosis / Q000097:blood / Q000188:drug therapy*; D003922:Diabetes Mellitus, Type 1 / Q000097:blood / Q000188:drug therapy; D011464:Epoprostenol / Q000097:blood; D005231:Fatty Acids, Unsaturated / Q000627:therapeutic use*; D006801:Humans; D008055:Lipids / Q000097:blood; D010974:Platelet Aggregation / Q000187:drug effects
D005231:Fatty Acids, Unsaturated; D008055:Lipids; D011464:Epoprostenol; D015126:8,11,14-Eicosatrienoic Acid